Health & MedicineTop StoryTop StoryLatest News
Male Contraceptive Pills are Back in the Spotlight: How Far Along has this Science Come?
Sentiment: NeutralHigh Priority
What Happened?
Researchers at Weill Cornell Medicine are developing a hormone-free male contraceptive pill that temporarily halts sperm motility, marking a significant advancement in male contraception.
Key points
- The experimental pill blocks the enzyme soluble adenylyl cyclase (sAC), essential for sperm movement.
- It should be taken 30 minutes before sex for maximum effectiveness, providing 6 to 8 hours of protection.
- Sperm motility and fertility levels recover within 24 hours after taking the pill.
- The research has received an $8.2 million grant from the NICHD for further development.
- Current male contraceptive options primarily include vasectomies and condoms.
Key insights
- The development of this pill may lead to increased male participation in contraception.
- If successful, it could shift societal perceptions about male contraceptive responsibility.
- The research highlights a growing interest in male contraceptive options beyond traditional methods.
Why it matters
This research could expand contraceptive options for men, challenging traditional views on male responsibility in family planning.
Tags
Entities
Weill Cornell Medicine· OrganizationNICHD· Organization
Source
Times Now
